Axsome Therapeutics Inc at Cowen Healthcare Conference (Virtual) Transcript
Hi, everyone, and thank you for joining us at our Cowen health care conference this year.
It is my pleasure to have with me today Dr. Herriot Tabuteau, CEO of Axsome Therapeutics.
Thank you very much for taking the time to join us today.
Maybe first, congratulations on all the progress that's happened over 2020. If you want to just outline maybe some of the key takeaways over the past 6 to 12 months and what we should be looking for over the course of 2021.
Well, first of all, Joe, thanks for having us at the Cowen health care conference.
So I'd say, if you look back to last year, it was a year when we focused on executing to make sure that we got to a point whereby we could file our NDA. So we had a lot of regulatory interactions. We had successful pre-NDA meetings with the FDA for AXS-05 in major depressive disorder, AXS-07 in the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
